AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANI PHARMACEUTICALS INC Director's Dealing 2020

Apr 8, 2020

31676_dirs_2020-04-08_b6f719ba-0d5c-4ed9-9968-530280b6da9c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2020-04-06

Reporting Person: Schrepfer Robert W (SVP - New Bus Dev & Spec Sales)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-06	Common Stock	F	666	$43.22	Disposed	53672	Direct
2020-04-07	Common Stock	F	396	$43.93	Disposed	53276	Direct

Footnotes

F1: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,000 shares of restricted stock, which was previously reported.

F2: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,188 shares of restricted stock, which was previously reported.